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Abstract Background: Adoles-
cents with tuberculosis (TB) form 
a significant proportion of child-
hood TB cases presenting with 
specifics clinical patterns. 
Objective: To describe the clinical 
presentation of tuberculosis in 
adolescent at National Hospital 
Abuja (NHA), Nigeria. 
Subjects and method: This is a 
descriptive and retrospective 
study of adolescents aged 10- 15 
years seen at the department of 
Paediatrics NHA Nigeria from 
August 2009 to July 2013.    
Result: Thirty- six adolescents 
diagnosed with tuberculosis were 
reviewed. Adolescent TB ac-
counted for 18.8%(36/192) of 
total cases of children aged 0-
15years seen at the Department of 
Paediatrics Respiratory Clinic 
during the study period. The mean 
(SD) age was 12.3(1.76) years. 
Twenty seven patients (75.0%) 
were females and 9(25.0%) were 
males. Thirty  (83.3%) were of 
lower socioeconomic class. His-
tory of contact with a case of TB 
was obtained in 17(47.2%). The 
commonest symptoms identified 
in these adolescents were; cough 
27(75.0%), weight loss 22
(61.1%), fever18(50.0%), sputum 
14(38.9%), body swelling  
7(19.4%), hemoptysis 2(5.6%); 
while signs were underweight, 
pyrexia and chest findings. Nine 
(25.0%) had associated retroviral 
disease. Thirty four (94.4%) pre-
sented at time of diagnosis with 
clinical symptoms while 2(5.6%) 
were asymptomatic; identified 
during contact tracing as latent TB 
infection (LTBI). Abnormal chest 
radiograph findings were; wide-
spread lung infiltrate in 10(27.8%), 
hilar opacities 7(19.4%), cavita-
tory lesions 4(11.1%), pleural  
Effusion 3(8.3%) and military 
opacities 1(2.7%). AFB was  
isolated in 5(13.9%), while  
23(63.9%) had a raised ESR above 
30mm/hr. Twenty seven (75.0%) 
of the adolescents completed treat-
ment for tuberculosis, 7(19.4%) 
were lost to follow up and  
2(5.6%) died while 4(11.1%) had 
re-treatment for TB from  relapse. 
Clinical presentations were pulmo-
nary TB (PTB) 22(61.1%), and 
extrapulmonary TB 12(33.3%); 
distributed as TB adenitis  
4(11.1%), TBM 3(8.3%), Pericar-
dial TB 3(8.3%), Miliary TB  
1(2.8%) and Spinal TB 1(2.8).  Of 
the  nine  with HIV- TB coinfec-
tion, the clinical presentation were;  
PTB 5(55.6%), and  
extrapulmonary 4(44.4%).  
Conclusion: The patterns of TB in 
adolescents are admixture as seen 
in younger children and adult from 
clinical and radiological character-
istic findings. TB remains a pre-
ventable disease condition and is 
curable with early appropriate 
treatment 
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Introduction  
 
The adolescent person whose age is between 10 -19 
years, has been described generally to be a healthy 
group compared to the general population, despite their
known high risk behavior1. The adolescent who is also a 
young person suffers from TB along with other mem-
bers of the general population2,3. In 2012, WHO esti-
mates that 8.6 million incident cases of TB were re-
ported with 530,000 new case of TB being children less 
than 15 years  and 74,000 child deaths from the disease2. 
These estimate were higher than the report published in 
the preceding year reflecting that more TB cases were 
being notified among children globally2.     Over 30  
million Nigerians (approximately 22 percent) are be-
tween the ages of 10-19.4 The adolescents and Young 
people represent a high risk sexual behavior groups that 
are highly vulnerable to HIV /AIDs infection and conse-
quently at risk of TB, in the dual pandemic5.  
 
The younger child, under five have been shown to be at 
greater risk of TB especially in the presence of malnutri-
tion and lower family socioeconomic background6,7. 
Childhood TB cases proportions in countries vary from 
3- 40percent 2.  Nigeria is among the 22 high burden 
nations with TB, accounting for 80percent of the world 
TB cases.  An estimated 1.1 million (13percent) of the
8.6 million people who developed TB in 2012 were HIV 
positive with 75 percent in the African region2. This 
ancient and still ongoing TB scourge  is caused by the 
mycobacterium tuberculosis complex, with   high and 
low prevalence  worldwide  despite available measure   
that highlight how to addressed and control the disase.8 
9The young person will be at risk of TB infection when 
in contact with a case of TB disease who is actively 
coughing, especially when he is immune compromised, 
is homeless or lives in congested camps, prison or jail, 
or nursing home and have risky behaviors such as intra-
venous drug use2, 3. 
 
There are few reports that have focused on TB burden in 
the adolescent. In the United States, adolescents com-
prised approximately one-third of the pediatric cases 
reported from 1994 to 20103. The  younger child, par-
ticularly the under-fives play little role in the transmis-
sion of TB because they more often have negative 
smears; they rarely have cavitary disease; they often 
have little or no cough; and when cough is present, it is 
generally not forceful enough to expel aerosolized ba-
cilli efficiently.10   In contrast, the 10- to 19-year age 
group presents a different spectrum of disease manifes-
tations, including adult-type disease, from which respi-
ratory samples can be more readily obtained2.  The Stop 
TB Partnership goals include reducing the global burden 
of TB (prevalence and mortality) by 50 per cent in 2015 
compared with 1990 levels and eliminating TB as a pub-
lic health problem by 205011.  In other to achieve this 
goal, the adolescent though largely a subset of the paedi-
atric age group  but differ remarkably from the younger 
child should be viewed differently since preventive 
measure for TB differ for the child and the adult. 
The study aims to describe the clinical presentation and 
outcome of adolescent tuberculosis at National Hospital 




Subjects and Method 
 
This is a retrospective, descriptive study, conducted at 
the Paediatric Respiratory Clinic of National Hospital 
Abuja. The clinic is held once weekly with average  
attendance of 15 patients seen per week. The case fold-
ers of adolescents aged 10- 15 years seen at the clinic 
from August 2009 to July 2013 who were diagnosed 
with tuberculosis were retrieved.  
The protocol for diagnosis of tuberculosis in the clini  
were based on: 
 
Bacteriological identification of mycobacterium tuber-
culosis complex by direct smear microscopy performed 
using auramine-rhodamine and confirmed with Kinyoun 
stain on clinical specimen in a patient with suggestiv  
symptoms and signs or 
Clinical diagnoses based on a combinationof symptoms 
and signs in the presence of any one or more of the fol-
lowing; a tuberculin skin test (TST) ≥10 mm for patients 
that are HIV negative or >5 mm in HIV positive pa-
tients, a history of contact with suspected tuberculosis 
patient, radiological and/ or histo-pathological finding 
from lymph node biopsy suggestive of TB.  Such clini-
cal features include a history  of  cough lasting for two 
weeks or more, sputum with or with haemoptysis,  pro-
longed fever for which patient has been treated with 
antibiotics with no improvement, weight loss or malnu-
trition and poor appetite. Other symptoms include con-
vulsions, loss of consciousness, swelling in the back or 
any other part of the body.  Signs recorded were also
retrieved including laboratory test results, treatment 
given with duration and outcome. Cultures were not 
done on any of the specimens. Only children aged less 
than 16 years were seen at the paediatric respiratory 
clinic as part of the hospital policy, while those 16 years 
and above were attended to by the adult physicians. 
 
A proforma was used to extract information relating to 
patient demography, clinical symptoms and signs, hi-
tory of contact, pattern of TB, radiological features, 
treatment and outcome (completion of treatment, los t  
follow up or retreatment for TB). All the patients were 
under care by the authors and case folders retrieved were 
analyzed after approval was obtained from the institu-
tional review board of the National hospital Abuja. Data 
were analyzed using Microsoft excel 2010 and mean 






A total of 52 adolescents aged 0-15 years diagnosed 
with  tuberculosis were documented in the paediatrics 
respiratory clinic record, but only 36 case folders with 
adequate information  retrieved from the hospital medi-
cal records were analyzed during the period August 
2009 to July 2013. This gives a prevalence rate of 18.8% 
(36/192).  The mean (SD) age was 12.3(1.76). 75.0% of 
the adolescents were females while 83.3% were of lower 
socioeconomic group as shown in table 1. 
 
Table 1: Socio-demographic characteristic of the study popu-
lation 











High social class 








34 patients (94.4%) were diagnosed after they present d 
with clinical symptoms while 2(5.6%) were identified 
through contact tracing as asymptomatic (latent TB 
cases). 17(47.2%) adolescents had a history of conta t 
with a person with suspected TB while 9(25.0%) had 
associated retroviral disease. Thirty two (88.9%) had a 
history of BCG given within one month of life. The 
most common symptoms identified were cough, weight 
loss and fever, while major signs were underweight, 
pyrexia and chest findings (respiratory distress, 
tachpnoea, crepitations, decreased percussion note and 
chest expansion); table 2. 
 
Acid- alcohol fast bacillus (AFB) was isolated in 5 
(13.9%) and 23 (63.9%) had a raised ESR above 30mm/
hr, Abnormal chest radiograph findings were; wide-
spread lung infiltrate 10 (27.8%), hilar opacities  
7(19.4%), cavitory lesions 4(11.1%), pleural effusion  
3(8.3%) and miliary opacities 1(2.8%). Twenty seven 
(75.0%) of the adolescents completed treatment for  
tuberculosis, 7(19.4%) were lost to follow up and  
2(5.6%) died., while 4(11.1%) had re-treatment for TB 
due to relapse. 
 
Table 2:  Common symptoms and signs identified in adoles-




















The clinical presentations of TB were; %) pulmonary 
TB (PTB) 22(61.1) and   extra-pulmonary TB 14
(38.9%); table 3 
 













Of the nine cases with HIV-TB co- infection, 5(55.6%) 
presented pulmonary disease while remaining 4 had 
extra- pulmonary diseases; namely TBM 2; pericardial 
TB and miliary TB one each; in Chart 1 
Symptoms N % 
Cough 27 75.0 
Weight loss 22 61.1 
Fever 18 50.0 
Sputum 14 38.9 
Body Swelling  (various sites) 7 19.4 
Headache 3 8.3 
Hemoptysis 2 5.6 
Swelling in the back 1 2.8 
Signs     
Underweight ≤80% 24 66.7 
Pyrexia 17 47.2 
Pallor 16 44.4 
Chest findings 15 41.7 
Hepatomegaly 11 30.6 
Lymphadenopathy 7 19.4 
Gibbus (thoracolumbar) 2 5.6 
Neck stiffness 1 2.8 





































The study describes the clinical characteristics of adoles-
cent TB at the National Hospital Abuja. Adolescent TB 
accounted for 18.8 percent of cases of TB seen during 
the study period. The female was at greater risk of TB in 
this report. Studies have documented that the prevalence 
of TB in children is higher in girl until between the age 
10 and 16 years12. The gender disparity becomes evi-
dence after fifteen years with a rising rate amongst male 
up till adulthood12.  Majority of the cases had active dis-
ease. This may be the reason why the prevalence was 
higher in the female since the progression from infection 
to active disease is more rapid in the female gender early 
in life and the reverse at older age12,13.  The young girl 
has been shown to have a threefold higher to acquire 
HIV infection  when  compared to  the male of same 
age. This risk factor for HIV may also  contribute to 
early active disease progression10.  Other factors that 
have been known to account for considerable variability 
in the outcome of M. tuberculosis infection include mal-
nutrition, poor socioeconomic status and immune sup-
pression such as caused by HIV4,5,14-16.  Over 60 percent 
of the study populations were undernourished with 
weights 80 percent or less for age and sex. Malnutrition 
interferes with the cell mediated immunity (CMI) re-
sponse and therefore contributes to much of the in-
creased frequency of TB in impoverished patients16.  
The TB rates were highest in the adolescent of lower 
socioeconomic status. The historical association of TB 
with low socioeconomic status and poverty had long 
been established14,15.  HIV/AIDS–TB co- infection co-
existed in twenty five percent of the adolescents. The 
dual disease burdens are known to adversely affect th  
outcome of each other. HIV impairs the host cellular 
immunity to contain TB infection and verse visa. The 
combination with HIV co-infection, dramatically com-
promises host resistance to TB, leading to high disease 
prevalence in affected endemic populations that include 
the adolescent.  With the current over half a million ado-
lescent infected with TB as at 2012,2 the risk for  in-
creasing prevalence of multidrug-resistant (MDR) and 
extensively drug-resistant (XDR) MTB strains17 and the 
more recent occurrence of TDR (totally drug-resistant) 
MTB strains, which are virtually untreatable18  becomes 
a challenge to all for early detection and treatment of all 
cases of TB.  
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Evidence of late presentation in 94.4 percent of the ado-
lescents studied was the presence of  clinical sympto s 
at time of diagnosis.  Such adolescents’ patients would 
have already contributed to infection transmission espe-
cially as they cough with sputum production in the pr s-
ence of AFP positive status acting as  reservoir of nfec-
tion to contacts. Late diagnosis results from this lack of 
early clinical suspicion of the disease.  Cough was the 
commonest symptom in the adolescent while 
38.9perecnt were able to produce sputum, unlike the 
younger child who most times cannot expectorate volun-
tarily.  Cough as a significant symptom was also found 
to be specific in a  report by Marais et al19 in which a 
persistent, non-remitting cough was reported in 15/16 
(93.8%) children under 13years with tuberculosis and in 
2/135 (1.5%) children  and young adolescents, without 
tuberculosis, indicating a specificity of 98.5%(135/137)
19.  The  use of well-defined symptoms,  even in re-
source limited settings  offer some value  in the diagno-
sis of childhood  and adolescent pulmonary tuberculosis. 
Sputum production with acid-alcohol fast bacillus 
(AFB) smear positivity is risk factors for transmission of 
infection among the adolescents and among his peers 
due to the high social interaction associated with this
age group. Close to 14 percent were bacteriological con-
firmed cases of TB in the present report. Contact with 
person with suspected TB is an important factor for ac-
quiring the infection seen in up to 47.2 percent of the 
adolescents. Early case finding from screening of con-
tacts of adolescents and adult cases of active cases re-
mains a strategy for the prevention and control of TB.
This also includes the use of isonaizid prophylaxis espe-
cially in under five children exposed to contacts of ac-
tive disease and HIV positive persons. All adolescents 
with a contact history must be evaluated with a TST for 
LTBI. Two cases were found to have LTBI in this re-
view and treated. The practice of LTBI treatment for TB 
contacts with a TST size of 10mm and above help re-
duce progression to disease.  This routine use of isoni-
azid preventive therapy (IPT) is an effective and cost-
effective intervention among child household contacts.  
 
The use of Bacillus Chalmette –Guerin (BCG) vaccine 
was high among the adolescents.  The BCG vaccine 
have been shown to have from zero to 80 percent effec-
tiveness  in preventing tuberculosis for a duration of 15 
years; however, its protective effect appears to vary ac-
cording to geography and the laboratory in which the
vaccine strain was grown20,21. A 1994 systematic review 
found that the BCG reduces the risk of getting TB by 
about 50%; (relative risk (RR) of TB of 0.49 (95% con-
fidence interval [CI], 0.34 to 0.70) for vaccine recipients 
compared with non-recipients (protective effect of 51%),  
and a protective effect   from tuberculous deaths  of 71% 
(RR, 0.29; 95% CI, 0.16 to 0.53), and  a protective ef-
fect  for meningitis  of 64% (OR, 0.36; 95% CI, 0.18 to 
0.70)22.    BCG is effective against rare forms of severe 
childhood TB meningitis and miliary disease, however, 
the variation in protection against common pulmonary 
TB that BCG offers has generally been disappointing in 
trials conducted in the developing world23,24.   This  pro-
tection of BCG for children from severe forms of TB in 
the first years of life, however  doesn’t prevent pulmo-
nary TB, which is prevalent in the adolescents and 
adults, who mostly spread the infection. A BCG that 
will prevent progression of latent TB to active disea e 
would be desirable; hence a vaccine that is more effec-
tive and safe against TB remains a task.  The possible 
role of a booster or replacement in the ongoing BCG 
trials may in future provide the solution to TB infection 
in the population that includes adolescents25. 
 
The patterns of TB in adolescents seen are a mixture of 
childhood forms and adult patterns in their clinical, r -
diological and microbiological findings. Most of the 
childhood TB forms seen were smear negative PTB 
similar to the finding reported by Cruz AT et al.3  For 
the extra- pulmonary forms, hilar lymphadenopathy was 
commonest followed by tuberculous meningitis and 
pericarditis occurring in equal proportion. A similar pat-
tern was also identified in the adolescent with retroviral 
disease. 
 
Imaging studies such as chest radiograph plays a signifi-
cant role in childhood TB diagnosis. A normal radio-
graphic study does not however rule out TB26. Abnormal 
chest radiograph findings were mostly widespread lung 
infiltrate (27.8 percent), hilar opacities (19.4percent), 
cavitatory lesions (11.1percent), pleural effusion 
(8.3percent) and miliary opacities (2.7percent). Tradi-
tionally, the two radiological patterns of TB manifesta-
tions that have been described are the primary TB and 
reactivation (post-primary) TB which relate to the pa-
tient immunity27. The present study shows a mixed form 
of both primary disease and reactivation TB, though 
primary pattern was more predominant. Children and the 
immunocompromised persons usually present with fea-
tures of primary TB which includes; parenchymal infil-
trates or consolidation within the lung parenchyma, in-
volving any pulmonary lobe or segment, hilar lymph 
node with or without atelectasis and unilateral pleural 
effusion on the same side of the primary focus of the 
TB28. In Reactivation TB, apical consolidations involv-
ing the upper lobe or superior segment of lower lobe are 
commonly seen with other features of cavitation, soli-
tary nodules and military picture min some cases28. The 
primary forms of TB were mostly those of hilar lymph 
node enlargement, (52.8 percent). Marias et al29 reported 
that up to 90- 95 percent of primary Tb in children are 
hilar lymph node enlargement which could be unilateral 
or bilateral and widespread in up to70 percent.  
 
Completion of treatment in TB is a significant part of 
disease control, as this stops transmission of infection 
from an active case to contacts. A 75percent complete 
treatment rate in the present report was slightly lower 
than the reported 85percent national figure (Nigeria 
2009 –2013)30. A loss to follow up or default from treat-
ment and poor compliance are risk factors for continuing 
infection transmission in the community with risk for 
resistance development and drug resistance TB.  Lost to 
follow up rate was 19.4percent; which is lower than e r-
lier  report by Jiya et al (36.5%) from  Sokoto in north-
west of Nigeria5. The Directly Observed Therapy (DOT) 
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strategy aim to improve treatment compliance and com-
pletion for the patients through a reliable supervisor of 
patients and accurate record keeping.  TB treatment in 
the adolescent can be a challenge resulting from the di-
verse behavioral, social and economic demography asso-
ciated with the development of the adolescent. This can 
lead to treatment discontinuation, resulting in perpetua-
tion of TB transmission in the community and appear-
ance of resistant strains. Death rate among the adoles-
cent was 5.6 percent; similar to the overall TB deaths of 
five percent for 2010 (Nigeria)31. 
Conclusion 
 
Tuberculosis remains a significant public health prob-
lem, particularly in resource limited settings like  
Nigeria. Late presentation was high in majority of ado-
lescent as they were symptomatic already before presen-
tation for diagnosis. A mixed pattern of disease was seen 
in the adolescent for a disease condition that remains 
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